Indivior Pharmaceuticals, Inc. INDV Business Segments — Net revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's business segments — net revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's business segments — net revenue?
- Indivior Pharmaceuticals, Inc. (INDV) reported business segments — net revenue of $317M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc. 's business segments — net revenue changed year-over-year?
- Indivior Pharmaceuticals, Inc. 's business segments — net revenue increased by 19.2% year-over-year, from $266M to $317M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc. 's business segments — net revenue?
- Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc. 's business segments — net revenue has grown at a 11.2% compound annual growth rate (CAGR), from $901M to $1.24B.
- What does business segments — net revenue mean?
- Represents the total gross sales generated by the reportable business segment after deductions for returns, allowances, and discounts. This metric serves as the primary indicator of the segment's market demand and top-line growth performance.